[go: up one dir, main page]

ES2103161B1 - Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos. - Google Patents

Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.

Info

Publication number
ES2103161B1
ES2103161B1 ES09301036A ES9301036A ES2103161B1 ES 2103161 B1 ES2103161 B1 ES 2103161B1 ES 09301036 A ES09301036 A ES 09301036A ES 9301036 A ES9301036 A ES 9301036A ES 2103161 B1 ES2103161 B1 ES 2103161B1
Authority
ES
Spain
Prior art keywords
derivatives
cyclloheptimidazole
compounds
manufacture
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09301036A
Other languages
English (en)
Other versions
ES2103161A1 (es
Inventor
Tsuyoshi Tomiyama
Akira Tomiyama
Takashi Yanagisawa
Naoto Ueyama
Tomoyuki Kawai
Motoharu Sonegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kotobuki Seiyaku Co Ltd
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of ES2103161A1 publication Critical patent/ES2103161A1/es
Application granted granted Critical
Publication of ES2103161B1 publication Critical patent/ES2103161B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADOS DE CICLOHEPTIMIDAZOL, METODO DE FABRICACION DE LOS MISMOS Y AGENTES TERAPEUTICOS QUE CONTIENEN ESTOS COMPUESTOS; LOS DERIVADOS DE CICLOHEPTIMIDAZOL ESTAN REPRESENTADOS POR LA FORMULA SIGUIENTE FORMULA (EN LA QUE R1 REPRESENTA H O GRUPO ISOPROPILO; R2 REPRESENTA ALQUILO INFERIOR; R3 REPRESENTA UN GRUPO DE ACIDO CARBOXILICO O TETRAZOL; A Y A1 SON GRUPOS SUSTITUIDOS EN LAS POSICIONES 4 U 8 Y A1 ES HIDROGENO O UN GRUPO HIDROXI CUANDO A ES HIDROGENO O A Y A1 ES UN GRUPO OXO; Y LA LINEA DE TRAZOS "----" REPRESENTA DOS DOBLES ENLACES O ENLACES SENCILLOS SATURADOS. SE PREPARAN HACIENDO REACCIONAR UN CICLOHEPTIMIDEZOL CON UN BIFENILO. SON UTILES COMO AGENTES ANTIHIPERTENSIVOS O AGENTES CONTRA EL FALLO CARDIACO CONGESTIVO.
ES09301036A 1992-05-22 1993-05-14 Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos. Expired - Fee Related ES2103161B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4131142A JP2707390B2 (ja) 1992-05-22 1992-05-22 シクロヘプトイミダゾ−ル誘導体及びその製造方法並びにこれを含有する薬剤

Publications (2)

Publication Number Publication Date
ES2103161A1 ES2103161A1 (es) 1997-08-16
ES2103161B1 true ES2103161B1 (es) 1998-04-01

Family

ID=15050986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09301036A Expired - Fee Related ES2103161B1 (es) 1992-05-22 1993-05-14 Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.

Country Status (10)

Country Link
US (1) US5409947A (es)
JP (1) JP2707390B2 (es)
KR (1) KR0152299B1 (es)
BE (1) BE1006419A3 (es)
DE (1) DE4316117C2 (es)
ES (1) ES2103161B1 (es)
FR (1) FR2691461B1 (es)
GB (1) GB2267089B (es)
IT (1) IT1265077B1 (es)
ZA (1) ZA933151B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
JP4316686B2 (ja) * 1994-09-05 2009-08-19 壽製薬株式会社 シクロヘプトイミダゾール誘導体
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
JP4018816B2 (ja) * 1998-09-08 2007-12-05 壽製薬株式会社 シクロヘプテノン誘導体及びその製造方法並びにそれを利用してシクロヘプトイミダゾール誘導体を製造する方法
JP2004501863A (ja) * 2000-01-19 2004-01-22 アルテオン　インコーポレーテッド チアゾール、イミダゾールおよびオキサゾール化合物、ならびにタンパク質老化関連疾患の治療
PL1673107T3 (pl) * 2003-10-10 2008-06-30 Abbott Laboratories Gmbh Kompozycja farmaceutyczna zawierająca selektywnego agonistę receptora imidazoliny I1 i bloker receptora angiotensyny II
JP4675586B2 (ja) * 2004-06-23 2011-04-27 壽製薬株式会社 高血圧症及び血清高尿酸血症の重複発症の治療のための薬剤
CN101119747A (zh) * 2004-07-02 2008-02-06 三共株式会社 组织因子产生抑制剂
KR101021828B1 (ko) 2004-10-27 2011-03-17 다이이찌 산쿄 가부시키가이샤 2 이상의 치환기를 갖는 벤젠 화합물
WO2025202469A1 (fr) * 2024-03-28 2025-10-02 Junia Utilisation d'un dérivé d'hinokitiol pour son activité antifongique et/ou antibactérienne sur les champignons, les oomycètes et/ou bactéries pathogènes des plantes et semences de culture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
US5104891A (en) * 1989-12-11 1992-04-14 G. D. Searle & Co. Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension

Also Published As

Publication number Publication date
DE4316117A1 (de) 1993-11-25
FR2691461A1 (fr) 1993-11-26
GB2267089A (en) 1993-11-24
ITMI931019A1 (it) 1994-11-18
BE1006419A3 (fr) 1994-08-23
FR2691461B1 (fr) 1994-11-10
GB2267089B (en) 1995-10-04
ITMI931019A0 (it) 1993-05-18
IT1265077B1 (it) 1996-10-30
DE4316117C2 (de) 2002-06-27
JPH05320139A (ja) 1993-12-03
KR0152299B1 (ko) 1998-10-15
GB9310492D0 (en) 1993-07-07
ZA933151B (en) 1993-12-06
JP2707390B2 (ja) 1998-01-28
ES2103161A1 (es) 1997-08-16
KR940005615A (ko) 1994-03-21
US5409947A (en) 1995-04-25

Similar Documents

Publication Publication Date Title
ES2064700T3 (es) Derivados de adenosina con actividad farmaceutica como antihipertensivos.
ES2168357T3 (es) Agonistas del receptor ep2 como agentes para disminuir la presion intraocular.
ES2103161B1 (es) Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.
ES2189330T3 (es) Derivados heterociclicos n6 de la adenosina sustituidos.
ES2152936T3 (es) Compuestos benzoheterociclicos.
ES2094719T3 (es) Derivados de pirazol y herbicidas que los contienen.
ES2058069T3 (es) Derivados de 5h-1,3,4-tiadiazolo-(3,2-a)-pirimidin-5-ona y nuevo compuesto fungicida agricola-horticola que contiene dicho derivado.
DK0513351T3 (da) 2-Nitroimidazolderivat, fremstilling deraf og strålingssensibilisator indeholdende samme som aktiv bestanddel
ES2123873T3 (es) Pirrolocarbazol.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES2110260T3 (es) Androstenonas.
ES2101073T3 (es) Nuevos aza-androstano-derivados 17-beta-substituidos.
AR241180A1 (es) Compuesto de benzisoxazol que incluye esteroisomeros del mismo y formulacion herbicida que lo contiene.
ES2003190A6 (es) Mezcla de productos activos exenta de silicato y de magnesio
YU46561B (sh) Postupak za stabilizaciju vodenog rastvora ranitidina
ES2167510T3 (es) Agentes para mejorar el sueño.
ES2028042T3 (es) Procedimiento para la obtencion de derivados de 1,8-naftiridina y fungidas que les contienen.
ES2010513B3 (es) Nuevos derivados de 6- o 7-metilenoandrosta-1,4-dieno3,17-diona y procedimiento para su preparacion.
MX9306588A (es) Compuesto de acilo antirretrovirales.
ES8603496A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina
ES2160726T3 (es) Derivados de piperazin-2,5-diona como moduladores de resistencia a multiples farmacos.
ATE122669T1 (de) Zearalanol-derivate mit anabolytischer wirkung.
ES2056194T3 (es) Compuestos tetraciclicos antidepresivos.
FI940003A0 (fi) Aminohappojohdannaiset
ES2061556T3 (es) Derivados amida y su produccion y fungicidas agricolas que los contienen.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970816

Kind code of ref document: A1

Effective date: 19970816

FD2A Announcement of lapse in spain

Effective date: 20180806